As of September 2024, Jagsonpal Pharmaceuticals has a market cap of $134.49M. This makes Jagsonpal Pharmaceuticals the world's 19529th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $99.23M | -18.21% |
2023 | $121.32M | 4.33% |
2022 | $116.28M | 108.36% |
2021 | $55.81M | 150.03% |
2020 | $22.32M | 178.40% |
2019 | $8.02M | -17.89% |
2018 | $9.76M | -17.85% |
2017 | $11.89M | 11.89% |
2016 | $10.62M | -30.30% |
2015 | $15.24M | 32.74% |
2014 | $11.48M | 306.63% |
2013 | $2.82M | -35.82% |
2012 | $4.40M | 31.16% |
2011 | $3.35M | -52.85% |
2010 | $7.11M | 14.86% |
2009 | $6.19M | 154.49% |
2008 | $2.43M | -75.12% |
2007 | $9.78M | 69.46% |
2006 | $5.77M | -53.87% |
2005 | $12.51M | 3.22% |
2004 | $12.12M | 78.46% |
2003 | $6.79M | 90.80% |
2002 | $3.56M | - |